Browse > Article
http://dx.doi.org/10.15432/JKTO.2015.20.1.045

The Role of Korean Medicine for Treatment and Management for Lung Cancer  

Jung, Hyun-Jung (Department of Diagnostics, College of Korean Medicine, Deagu Hanny University)
Kim, Jong-Dae (Department of Internal Medicine, College of Korean Medicine, Daegu Haany University)
Publication Information
Journal of Korean Traditional Oncology / v.20, no.1, 2015 , pp. 45-54 More about this Journal
Abstract
Objectives : Lung cancer is the leading cause of death in cancer patients. Many studies reflect the growing application of integrative korean and western medicine for lung cancer, but its efficacy remains largely unexplored. The purpose of this study is to show that the role of Korean medicine for treatment and manage for lung cancer patients. Methods : In the present study, we searched all the clinical studies of Korean Medical therapies for lung cancer by electronic and manual searching in two databases including MEDLINE, OASIS. Results : Our study showed that acupuncture has strong immunomodulatory effect. Further analysis revealed that acupuncture and herb medicine alleviate the conventional therapy-induced bone marrow supression in lung cancer patients, as well as desease nausea and vomiting. In this study, we showed that acupuncture and herb medicine can improve immediate tumor response, quality of life of lung cancer patients. Conclusions : Korean medicine including that acupuncture and herb medicine is found to be effective in lung cancer treatment and management.
Keywords
lung cancer; acupuncture; herb medicine; integrative medicine; korean medicine;
Citations & Related Records
Times Cited By KSCI : 13  (Citation Analysis)
연도 인용수 순위
1 National Cancer Information center. Cancer statistics. Available from http://www.cancer.go.kr/cms/statics/mortality/index
2 대한암한의학회 교재 편찬 위원회. 한의통합 종양학. 초판. p. 88, 131.서울, 군자출판사, 2013
3 Ernst E. Cassileth BR. The prevalence of complementary/alternative medicine in cancer a systemic review. Cancer 83:777-782, 1998   DOI
4 Choi JY. The present state of complementary and alternative medicine in the world. Research Institute for Healthcare Policy Korean Medical Association 5:34-41, 2007
5 Chang SB, Lee TW, Kim S, Yoo IY, Kim IS, Kang KH, Lee MK, Jang YH. A study of Complementary and Alternative Medicine used by Cancer Patients in Korea. J Korean Acad Adult Nurs 18;92-101, 2006
6 Chen HY, Li SG, Cho WC, Zhang ZJ. The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis. BMC Complementary and Alternative Medicine 13:36, 2013   DOI
7 Ezzo JM, Richardson MA, Vicker A, Allen C, Dibble S, Flssell B, Lao L, Pearl M, Ramirez G, Roscore HA, Shen J, Shivnan JC, Steitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane database syst Rev 2: CD002285, 2006
8 Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies. Auton Neurosci 129(1-2):107-117, 2006   DOI
9 Kwon KR, Kim HD, Kim JS, Yoo HS, Cho CK. Case series of Non-small Cell Lung cancer Treated with mountain Ginseng Pharmacopuncture. J. Acupunct Meridian Stud 4(11): 61-68, 2011   DOI
10 Hyun DS, Kim JD, Kwon HJ, Jung HJ. The Effectiveness of Acupuncture for Fatigue Severity in Lung Cancer Patients: Pilot Study. Korean Journal of Acupuncture 29(4):623-633, 2012
11 Kim DH, Jeon DS, Park SC, Lee SE, Cho WH, Han CW, Kim SY, Choi JY, Kim YS. Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients-A Single group before-and-after, preliminary study-.Korean J. Oriental Physiology & Pathology 28(1):82-88, 2014
12 Wong RH, Lee TW, Sihoe AD, Wan IY, Ng CS, Chan SK, Wong WW, Liang YM, Yim AP. Analgesic effect of electroacupuncture in post-thoracotomy pain: a prospective randomized trial. Ann Thorac Surg 81(6):2031-2036, 2006   DOI
13 He H, Zhou X, Wang Q, Zhao Y. Does the Couse of Astragalus-Containing Chinese Herbal Prescriptions and Radiotherapy Benefit to Non-Small-Cell Lung Cancer Treatment: A Meta-Analysis of Randomized Trials. Evidence-Based Complementary and Alternative Medicine Article 2013:ID426207, 2013
14 Li SG, Chen HY, Ou-Yang CS, Wang XX, Yang ZJ, Tong Y, Cho W. The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. PLOS ONE 8(2):eS7604, 2013
15 유승후, 유화승, 조종관, 이연월. 항암단을 투여한 재발성 편평상피폐암 환자에 대한 7년간의 추적조사. 대한한방내과학회지 28(2):385-390, 2007
16 Lee NH, Yoon DH, Yoo HS, Cho JH, Son CG, Lee YW. Changes of Serum VEGF, bFGF levels and platelet counts in 100 cancer patients treated with HangAmDan (HAD). Korean J. Orient. Int. Med 26(4):753-60, 2005
17 김구, 최용석, 주종천, 문구. 산양산삼 약침치료로 종양 퇴축을 보인 폐암환자에 대한 증례보고. 대한약침학회지 14(4):33-38, 2011   DOI
18 박봉기, 유화승, 이연월, 한성수, 조정효, 손창규, 조종관. 수레바퀴 암치료법을 시행한 폐암환자에 대한 후향적 코호트 분석. 대한한방내과학회 추계학술대회:45-56, 2008
19 Kim MK, Lee JS, Lee SH, Jung HS, Choi WC, Kim KS. A clinical case of patient with cancer pain treated by moxibustion. J of Kor. Traditional Oncology 14(1):53-59, 2009
20 방선휘, 권기록, 유화승. 산삼약침 혈맥주입을 시행한 비소세포폐암 환자 2례. 대한약침학회 11(2):13-19, 2008   DOI
21 박봉기, 조종관, 권기록, 유화승. 6개월간 산삼약침요법을 시행받은 IIIB기 편평세포폐암 환자에 대한 증례보고. 대한약침학회지 10(3):143-147, 2007   DOI
22 송안나, 안지혜, 김경석, 정현식, 이수경, 최원철. 알러젠 제거 옻나무 추출물 단독 치료로 생존기간 연장 및 살의 질 개선을 보인 진행성 비소세포폐암 환자 1례. 대한암한의학회지 17(1):39-43, 2012
23 김은희, 박소정, 최원철, 이수경. 알러젠 제거 옻나무 추출물 투여로 생존기간이 연장된 편평세포폐암 환자 1례. 대한암한의학회지 16(2):35-41, 2011
24 권은미, 정의민, 김경석, 이수경, 최원철, 윤성우. 알러젠 제거 옻나무 추출물 위주의 한방치료와 항암화학요법을 병용한 폐암 환자 2례. 대한암한의학회지 14(1):13-20, 2009
25 유승민, 어완규, 윤성우. 알러젠 제거 옻나무 추출물 투여로 삶의 질 개선과 생존기간 연장을 보인 비소세포폐암 환자1례. 대한암한의학회지 13(1):63-69, 2008
26 최성헌, 송안나, 안지혜, 김은희, 박소정, 이수경, 김경석. 알러젠 제거 옻나무 추출물 투여로 생존기간이 연장된 4기 비소세포폐암 환자 1례. 대한암한의학회지 17(1):45-53, 2012
27 박형준, 안지혜, 이진수, 정의홍, 이상헌, 전성하, 정현식, 김경석, 최원철. 알러젠 제거 옻나무 추출물을 투여한 고령의 진행성 비소세포폐암 환자 1례. 대한암한의학회지 15(1):71-77, 2010
28 최규희, 방지현, 김재환, 정승기, 정희재. 폐엽절제술 후 견배부 통증을 호소한 폐암 환자 치험 1례. 대한암한의학회지 15(1):79-87, 2010
29 김경순, 정태영, 유화승, 이연월, 조종관. 항암플러스 투여로 호전된 진행성 비소 세포성 폐암 연속환자증례. 대한한방내과학회지 30(4):893-900, 2009
30 정홍매, 윤정원, 이연월, 조종관, 오달석, 유화승. 진행성 비소세포성 폐암환자에 대한 항암플러스의 치료효능: 연속증례보고. 대한한방내과학회지 32(1):113-120, 2011
31 박재우, 전형준, 조종관, 이연월. 한방치료 후 Gefitinib(Iresa) 복용으로 인한 부작용 호전된 비소세포폐암 환자 1례. 대한암한의학회지 17(1):9-16, 2012
32 박형준, 채진, 이진수, 정현식, 이상헌, 최원철, 김경석. 비소세포폐암 환자의 표시 성장인자 수용첵 억제제 치료와 관련된 피부의 이상반응이 사물탕 가감방 투여로 호전된 1례. 대한암한의학회지 16(1):55-61, 2011
33 박소정, 강휘중, 이연월, 조종관, 유화승. 비소세포성 폐암 4기 환자의 악성 흉수로 인한 증상이 이음전가미방으로 호전된 1례. 대한한방내과학회지 35(3):366-372, 2014
34 Yoon T. Targeted therapy and tailored chemotherapy for advanced non-small cell lung cancer, Korean J Med. 77(1):9-17, 2009
35 Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350(21):2129-2139, 2004   DOI
36 Kim HR, Jeong HR, Geak DG, Won JH, Moon G. Clinical Practice Guidelines of Korean Medicine for Gastric Cancer. J of Kor. Treaditional Oncology 19(1):1-24, 2014   DOI
37 이귀녕, 권오헌. 임상병리파일. 3판. p.1525-36. 서울, 의학문화사, 2000
38 Cantrell DA, Smith KA. The interleukein-2 T cell system: a new cell growth model. Science 224:1312-1316, 1984   DOI
39 National Cancer Institute. Levels of Evidence for Human Studies of Cancer Complementary and Alternative Medicine, Available from :URL: http://www.cancer.gov/cancertopics/pdq/levels-evidence-cam/HealthProfessional/page3
40 Viver E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cellsand natural killer T cells in cancer. Nat Rev Immunol 2012;12:239-52.   DOI